A detailed history of Richard Bernstein Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Richard Bernstein Advisors LLC holds 9,050 shares of VRTX stock, worth $4.08 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
9,050
Previous 9,050 -0.0%
Holding current value
$4.08 Million
Previous $4.24 Million 0.78%
% of portfolio
0.09%
Previous 0.1%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $785 - $971
2 Added 0.02%
9,050 $4.24 Million
Q1 2024

May 09, 2024

SELL
$407.69 - $446.08 $1.09 Million - $1.2 Million
-2,684 Reduced 22.88%
9,048 $3.78 Million
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $501,814 - $561,648
-1,596 Reduced 11.97%
11,732 $4.13 Million
Q2 2022

Aug 02, 2022

BUY
$234.96 - $292.55 $3.13 Million - $3.9 Million
13,328 New
13,328 $3.76 Million
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $758,514 - $995,071
-3,364 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $2.25 Million - $2.8 Million
-11,286 Reduced 77.04%
3,364 $800,000
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $990,398 - $1.11 Million
-5,958 Reduced 28.91%
14,650 $2.48 Million
Q3 2018

Nov 13, 2018

BUY
$167.73 - $192.74 $3.46 Million - $3.97 Million
20,608 New
20,608 $3.97 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Richard Bernstein Advisors LLC Portfolio

Follow Richard Bernstein Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richard Bernstein Advisors LLC with notifications on news.